Seven Saxena White Attorneys Named to the 2024 Lawdragon “500 Leading Plaintiff Financial Lawyers” Guide

The 2024 “Lawdragon 500 Leading Plaintiff Financial Lawyers” guide has named seven Saxena White attorneys among their list of top national practitioners who “go to bat when their clients have been swindled, defrauded, shut out of markets, bamboozled and just plain lied to.”

The attorneys recognized are:

Some of the high-profile recent matters that these honorees have achieved include:

  • $180 million cash recovery (largest ever in Sixth Circuit) and adoption of groundbreaking corporate governance reforms in action arising from FirstEnergy bribery scandal.
  • $240 million cash recovery from Wells Fargo in derivative action related to the well-known “fake account” scandal at the bank.
  • Goldman Sachs Group Derivative Litigation – $79.5 million monetary recovery—second largest derivative recovery in the history of the Second Circuit—as well as important corporate governance reforms designed to improve Goldman Sachs’s compliance systems.
  • $28 million recovery for investors from ProAssurance Corporation, one of the largest medical liability insurance providers in the United States, and certain of its senior executives, for alleged violations of the federal securities laws.
  • $30 million recovery for shareholders from specialty insurance provider James River Group Holdings, Ltd., and certain of its senior executives, for allegedly failing to disclose material adverse facts about the Company’s business and artificially inflating the Company’s stock price.
  • Major corporate reforms obtained through shareholder derivative action alleging the leadership of home automation (security, comfort and smart-technology solutions and products) company Resideo Technologies Inc. caused a decline in stock value following a 2018 spinoff from Honeywell International Inc.
  • $28.5 million all-cash recovery for Fibrogen in action alleging that the biopharmaceutical company manipulated clinical safety data of its flagship chronic kidney disease drug, Roxadustat.
  • Obtained $129 million in new shares for common stock for shareholders of AMC Entertainment in action alleging AMC attempted to improperly override the voting rights of its common stockholders by issuing a new class of equity and rigging the vote to favor the interests of that new equity class.

Legal periodical Lawdragon is well-known for its rankings and editorial coverage of the nation’s leading lawyers.

For the complete list of the 2024 “Lawdragon Leading Plaintiff Financial Lawyers,” view here.